Literature DB >> 20184376

Peroxynitrite induces destruction of the tetrahydrobiopterin and heme in endothelial nitric oxide synthase: transition from reversible to irreversible enzyme inhibition.

Weiguo Chen1, Lawrence J Druhan, Chun-An Chen, Craig Hemann, Yeong-Renn Chen, Vladimir Berka, Ah-Lim Tsai, Jay L Zweier.   

Abstract

Endothelial nitric oxide synthase (eNOS) is an important regulator of vascular and cardiac function. Peroxynitrite (ONOO(-)) inactivates eNOS, but questions remain regarding the mechanisms of this process. It has been reported that inactivation is due to oxidation of the eNOS zinc-thiolate cluster, rather than the cofactor tetrahydrobiopterin (BH(4)); however, this remains highly controversial. Therefore, we investigated the mechanisms of ONOO(-)-induced eNOS dysfunction and their dose dependence. Exposure of human eNOS to ONOO(-) resulted in a dose-dependent loss of activity with a marked destabilization of the eNOS dimer. HPLC analysis indicated that both free and eNOS-bound BH(4) were oxidized during exposure to ONOO(-); however, full oxidation of protein-bound biopterin required higher ONOO(-) levels. Additionally, ONOO(-) triggered changes in the UV/visible spectrum and heme content of the enzyme. Preincubation of eNOS with BH(4) decreased dimer destabilization and heme alteration. Addition of BH(4) to the ONOO(-)-destabilized eNOS dimer only partially rescued enzyme function. In contrast to ONOO(-) treatment, incubation with the zinc chelator TPEN with removal of enzyme-bound zinc did not change the eNOS activity or stability of the SDS-resistant eNOS dimer, demonstrating that the dimer stabilization induced by BH(4) does not require zinc occupancy of the zinc-thiolate cluster. While ONOO(-) treatment was observed to induce loss of Zn binding, this cannot account for the loss of enzyme activity. Therefore, ONOO(-)-induced eNOS inactivation is primarily due to oxidation of BH(4) and irreversible destruction of the heme/heme center.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20184376      PMCID: PMC2851177          DOI: 10.1021/bi9016632

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  59 in total

Review 1.  Nitric oxide: pathophysiological mechanisms.

Authors:  S S Gross; M S Wolin
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

2.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Characterization of recombinant human endothelial nitric-oxide synthase purified from the yeast Pichia pastoris.

Authors:  A Leber; B Hemmens; B Klösch; W Goessler; G Raber; B Mayer; K Schmidt
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

4.  N omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine.

Authors:  D J Stuehr; N S Kwon; C F Nathan; O W Griffith; P L Feldman; J Wiseman
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

5.  Superoxide and peroxynitrite in atherosclerosis.

Authors:  C R White; T A Brock; L Y Chang; J Crapo; P Briscoe; D Ku; W A Bradley; S H Gianturco; J Gore; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

6.  In vivo atherosclerotic plaque characterization using magnetic susceptibility distinguishes symptom-producing plaques.

Authors:  Subha V Raman; Marshall W Winner; Tam Tran; Murugesan Velayutham; Orlando P Simonetti; Peter B Baker; John Olesik; Beth McCarthy; Amy K Ferketich; Jay L Zweier
Journal:  JACC Cardiovasc Imaging       Date:  2008-01

7.  Redox function of tetrahydrobiopterin and effect of L-arginine on oxygen binding in endothelial nitric oxide synthase.

Authors:  Vladimir Berka; Hui-Chun Yeh; De Gao; Farheen Kiran; Ah-Lim Tsai
Journal:  Biochemistry       Date:  2004-10-19       Impact factor: 3.162

8.  Evidence for a bidomain structure of constitutive cerebellar nitric oxide synthase.

Authors:  E A Sheta; K McMillan; B S Masters
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

9.  Cysteine 99 of endothelial nitric oxide synthase (NOS-III) is critical for tetrahydrobiopterin-dependent NOS-III stability and activity.

Authors:  P F Chen; A L Tsai; K K Wu
Journal:  Biochem Biophys Res Commun       Date:  1995-10-24       Impact factor: 3.575

10.  Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimer.

Authors:  P Klatt; K Schmidt; D Lehner; O Glatter; H P Bächinger; B Mayer
Journal:  EMBO J       Date:  1995-08-01       Impact factor: 11.598

View more
  48 in total

Review 1.  Sex, Oxidative Stress, and Hypertension: Insights From Animal Models.

Authors:  Jane F Reckelhoff; Damian G Romero; Licy L Yanes Cardozo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

Review 2.  Reactive oxygen species in cancer stem cells.

Authors:  Xiaoke Shi; Yan Zhang; Junheng Zheng; Jingxuan Pan
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

Review 3.  S-glutathionylation reshapes our understanding of endothelial nitric oxide synthase uncoupling and nitric oxide/reactive oxygen species-mediated signaling.

Authors:  Jay L Zweier; Chun-An Chen; Lawrence J Druhan
Journal:  Antioxid Redox Signal       Date:  2011-03-27       Impact factor: 8.401

4.  Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis.

Authors:  Biljana Musicki; Tongyun Liu; Sena F Sezen; Arthur L Burnett
Journal:  J Sex Med       Date:  2012-05-23       Impact factor: 3.802

Review 5.  The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism.

Authors:  Javier Inserte; David Garcia-Dorado
Journal:  Br J Pharmacol       Date:  2015-03-16       Impact factor: 8.739

Review 6.  Redox Control of Vascular Function.

Authors:  Joseph C Galley; Adam C Straub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-12       Impact factor: 8.311

Review 7.  Nitric oxide signalling in cardiovascular health and disease.

Authors:  Charlotte Farah; Lauriane Y M Michel; Jean-Luc Balligand
Journal:  Nat Rev Cardiol       Date:  2018-02-01       Impact factor: 32.419

Review 8.  eNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity.

Authors:  Ruslan Rafikov; Fabio V Fonseca; Sanjiv Kumar; Daniel Pardo; Charles Darragh; Shawn Elms; David Fulton; Stephen M Black
Journal:  J Endocrinol       Date:  2011-06-03       Impact factor: 4.286

9.  Cardiac resynchronization therapy and reverse molecular remodeling: importance of mitochondrial redox signaling.

Authors:  Jay L Zweier; Chun-An Chen; M A Hassan Talukder
Journal:  Circ Res       Date:  2011-09-16       Impact factor: 17.367

10.  Angiotensin II impairs endothelial nitric-oxide synthase bioavailability under free cholesterol-enriched conditions via intracellular free cholesterol-rich membrane microdomains.

Authors:  Eisuke Amiya; Masafumi Watanabe; Norihiko Takeda; Tetsuya Saito; Taro Shiga; Yumiko Hosoya; Tomoko Nakao; Yasushi Imai; Ichiro Manabe; Ryozo Nagai; Issei Komuro; Koji Maemura
Journal:  J Biol Chem       Date:  2013-04-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.